WHAT WE SEE TRENDING NOW...
New Imaging Agent Being Tested for Early Detection of Alzheimer’s
A new imaging agent currently in Phase III clinical trials could soon make it possible
for more radiologists to see beta-amyloid — the brain plaque
associated with suspected Alzheimer’s disease — through
PET scans
READ MORE ABOUT THIS IN
DIAGNOSTIC IMAGING
New Technologies
offered by
Delta Imaging Systems, Inc.
SAPHENEIA
What is your facility doing about reducing CT dose
...with your older CT's?
Are you seeing greater than 30% dose reduction in your
newer CT's?
See for yourself: Sapheneia.com
TM
